Press releases | WebDisclosure

REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

IMERYS_Communique-de-presse_RA2025_FR_19Fev2026_VF
REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

IMERYS_Press_Release_FY2025_ENG_19Feb2026_VF
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. Company specializes in acquiring European pharmaceutical subcontractors

Pharmaceutical Transparency Notification Shareholding Oxurion NV European Subcontractors
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

RÉSULTATS SEMESTRIELS 2025-26 À L'ÉQUILIBRE
Miliboo publie des résultats semestriels solides : croissance du CA de +6,6%, marge brute à 60,6%, EBITDA à l'équilibre. Situation financière renforcée par nouveaux emprunts

Croissance Résultats Semestriels EBITDA Situation Financière Miliboo
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en specialiseert zich in farmaceutische onderaannemers

Transparantiekennisgeving Oxurion NV België Farmaceutische Onderaannemers Aandelenverkoop
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement
REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

IMERYS_Communique-de-presse_RA2025_FR_19Fev2026_VF
REGULATED PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

IMERYS_Press_Release_FY2025_ENG_19Feb2026_VF
PRESS RELEASE

published on 02/19/2026 at 18:00, 2 months 17 days ago

THX Pharma publie sa position de trésorerie au 31 décembre 2025
THX Pharma annonce une trésorerie disponible de 7,764 k€ au 31 décembre 2025, renforcée par un accord avec Biocodex pour un versement de 12 M€ en mars 2026. Prochaine publication : Résultats financiers annuels le 28 avril 2026

Résultats Financiers Trésorerie Accord THX Pharma Biocodex
PRESS RELEASE

published on 02/19/2026 at 17:52, 2 months 17 days ago

Marie Brizard Wine & Spirits: Q4 2025 and full-year 2025 revenues
Marie Brizard Wine & Spirits reports FY 2025 revenues of €172.0m (-8.6% vs 2024) and Q4 2025 revenues of €44.6m (-6.9%). Global spirits market slowdown impacts sales, with French market hit by delistings

Revenues Marie Brizard Wine & Spirits Q4 2025 Global Spirits Market

Published on 05/09/2026 at 01:55, 12 hours 15 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 12 hours 30 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 12 hours 40 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 14 hours 10 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 15 hours 9 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 17 hours 32 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 18 hours 58 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 19 hours 8 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 19 hours 41 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 19 hours 41 minutes ago

Designated Person Notification

View all EQS

Published on 05/07/2026 at 19:15, 1 day 18 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 18 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 19 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 19 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 19 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News